Scholarly Index
Jessica Zucman‐Rossi
Inserm; 65,471 total citations; 500 total publications; best world rank #31
Inserm
65,471Total citations
500Total publications
106H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 66 | FR 9 | 99.67 |
| Cancer Mechanisms and Therapy | Lifetime | 31 | FR 1 | 99.39 |
| Cancer Genomics and Diagnostics | Lifetime | 359 | FR 17 | 99.33 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 227 | FR 18 | 98.92 |
| Liver physiology and pathology | Lifetime | 127 | FR 4 | 98.70 |
| Ferroptosis and cancer prognosis | Lifetime | 242 | FR 8 | 97.02 |
| Cancer-related gene regulation | Lifetime | 379 | FR 4 | 98.02 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 151 | FR 7 | 98.15 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 571 | FR 14 | 94.37 |
| Chromatin Remodeling and Cancer | Lifetime | 470 | FR 28 | 89.75 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 213 | FR 17 | 97.48 |
| Cancer Genomics and Diagnostics | 2021-2025 | 624 | FR 22 | 96.12 |
| Hepatitis B Virus Studies | 2021-2025 | 353 | FR 14 | 93.99 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 785 | FR 30 | 89.59 |